AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15721217 — intervention group
Group type: EXPERIMENTAL
Intervention: Right rTMS
Number of subjects: 39
Study 15721217 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 39
Study 14512398 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored fluorouracil, epirubicin, and cyclophosphamide (FEC) therapy for nine courses
Number of subjects: 525
Study 14512398 — intervention group
Group type: COMPARATOR
Intervention: Induction FEC therapy for three courses followed by high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin (CTCb)
Number of subjects: 525
Study 14512398 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (FEC and CTCb)
Number of subjects: 525
Study 11249802 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (900 to 3,600 mg/day)
Number of subjects: 0
Study 11249802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11249802 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study 9032851 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma Knife radiosurgery
Number of subjects: 50
Study 1888819 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg cimetidine suspension four times daily
Number of subjects: 125
Study 1888819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 3514018 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine; utilized for 10 days
Number of subjects: 10
Study 3514018 — intervention group
Group type: COMPARATOR
Intervention: Placebo; during the placebo period
Number of subjects: 10
Study 28951431 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Exercise (PE)
Number of subjects: 821
Study 28951431 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based Cognitive Behavioural Therapy (ICBT)
Number of subjects: 821
Study 28951431 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 821
Study 28951431 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated work ability
Number of subjects: 821
Study 26394646 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (S)
Number of subjects: 39
Study 26394646 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin + Ezetimibe (S+E)
Number of subjects: 39
Study 26394646 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo run-in period)
Number of subjects: 39
Study 24753128 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization
Number of subjects: 1176
Study 22866941 — intervention group
Group type: EXPERIMENTAL
Intervention: TV Commercial Stepping
Number of subjects: 58
Study 22866941 — intervention group
Group type: COMPARATOR
Intervention: Walking 30 min/day
Number of subjects: 58
Study 19931380 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated, subvirion vaccine containing 15microg of influenza A/H5N1 hemagglutinin (HA) by the intramuscular (IM) route
Number of subjects: 100
Study 19931380 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated, subvirion vaccine containing 45microg of influenza A/H5N1 hemagglutinin (HA) by the intramuscular (IM) route
Number of subjects: 100
Study 19931380 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated, subvirion vaccine containing 3microg of H5 HA by the intradermal (ID) route
Number of subjects: 100
Study 19931380 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated, subvirion vaccine containing 9microg of H5 HA by the intradermal (ID) route
Number of subjects: 100
Study 19931380 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated, subvirion vaccine containing 45microg of H5 HA by the intramuscular (IM) route
Number of subjects: 100
Study 19931380 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated, subvirion vaccine containing 15microg of H5 HA by the intramuscular (IM) route
Number of subjects: 100
Study 22863058 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g colestyramine
Number of subjects: 9
Study 22863058 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g colestyramine
Number of subjects: 9
Study 22863058 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of colestyramine
Number of subjects: 9
Study 22863058 — intervention group
Group type: COMPARATOR
Intervention: Control (water alone)
Number of subjects: 9
Study 16450921 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual feedback provided during the FAAF test
Number of subjects: 32
Study 16450921 — intervention group
Group type: COMPARATOR
Intervention: No visual feedback provided during the FAAF test
Number of subjects: 32
Study 12615670 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone (8 mg)
Number of subjects: 30
Study 12615670 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 9854438 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcement for choosing the word in each pair that contained a double letter.
Number of subjects: 0
Study 9854438 — intervention group
Group type: COMPARATOR
Intervention: Encouragement to test irrelevant hypotheses.
Number of subjects: 0
Study 9854438 — intervention group
Group type: COMPARATOR
Intervention: Sitting in an uncomfortable chair.
Number of subjects: 0
Study 9121751 — intervention group
Group type: EXPERIMENTAL
Intervention: Excimer laser photorefractive keratectomy (PRK)
Number of subjects: 107
Study 2483004 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant PVB therapy
Number of subjects: 56
Study 2483004 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant CAP therapy
Number of subjects: 56
Study 55648 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole (1-25 mg/kg twice daily for two consecutive days every week)
Number of subjects: 70
Study 55648 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole (greater than 2-5 mg/kg/day)
Number of subjects: 70
Study 55648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 30983001 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% triamcinolone acetonide cream with wet wraps
Number of subjects: 39
Study 30983001 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% triamcinolone acetonide ointment with wet wraps
Number of subjects: 39
Study 30983001 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient preference for ointment
Number of subjects: 39
Study 28684191 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitrate (15 mmol)
Number of subjects: 10
Study 28684191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 25324159 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Childhood Oral Health Impact Scale (ECOHIS)
Number of subjects: 286
Study 23350579 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (10 mL of Evicel)
Number of subjects: 24
Study 23350579 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 24
Study 21722228 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (500-1000 mg) + Ibuprofen (100-400 mg)
Number of subjects: 0
Study 21722228 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (100-400 mg)
Number of subjects: 0
Study 21722228 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (500-1000 mg)
Number of subjects: 0
Study 18457747 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention using SMS and Internet for 6 months
Number of subjects: 34
Study 16517327 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (300000 IU intravenously before XU)
Number of subjects: 16
Study 16517327 — intervention group
Group type: COMPARATOR
Intervention: Control (no additional treatment)
Number of subjects: 16
Study 12968959 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservation of the intercostobrachial (ICB) nerve
Number of subjects: 85
Study 12968959 — intervention group
Group type: COMPARATOR
Intervention: Nerve section
Number of subjects: 85
Study 12968959 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 85
Study 10620007 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplements and dietary counselling
Number of subjects: 15
Study 10620007 — intervention group
Group type: COMPARATOR
Intervention: Control (no supplements or specific nutritional advice)
Number of subjects: 15
Study 9020549 — intervention group
Group type: EXPERIMENTAL
Intervention: Newborns with premature ablation of placenta
Number of subjects: 20
Study 9020549 — intervention group
Group type: COMPARATOR
Intervention: Healthy newborns
Number of subjects: 20
Study 1585291 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg twice a day for 10 days
Number of subjects: 82
Study 1585291 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin 500 mg six hourly for 10 days
Number of subjects: 82
Study 1585291 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 82
Study 1585291 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 82
Study 1585291 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 82
Study 4032549 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 gm. ampicillin intramuscularly in divided doses 1 hour before, at the time of, and 6 hours after catheter insertion (Group 1)
Number of subjects: 78
Study 4032549 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gm. ampicillin intramuscularly every 8 hours (Group 2)
Number of subjects: 78
Study 4032549 — intervention group
Group type: COMPARATOR
Intervention: No antimicrobial prophylaxis (Group 3)
Number of subjects: 78
Study 4032549 — intervention group
Group type: COMPARATOR
Intervention: Group 3 (Control)
Number of subjects: 78
Study 28936572 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot spring balneotherapy for 5 months
Number of subjects: 362
Study 28936572 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 362
Study 27137122 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration and electromyostimulation (WBV+ES)
Number of subjects: 17
Study 27137122 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 17
Study 24662223 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded vibration (LV) training group (n = 7)
Number of subjects: 21
Study 24662223 — intervention group
Group type: EXPERIMENTAL
Intervention: Unloaded vibration (ULV) training group (n = 7)
Number of subjects: 21
Study 24662223 — intervention group
Group type: COMPARATOR
Intervention: Loaded training (LT) group (n = 7)
Number of subjects: 21
Study 21956438 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenously administered 6% v/v ethanol to a target blood alcohol concentration of 0.08%
Number of subjects: 2
Study 21956438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 21956438 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenously administered 6% v/v ethanol
Number of subjects: 2
Study 20158918 — intervention group
Group type: EXPERIMENTAL
Intervention: $AUD5 payment per chlamydia test
Number of subjects: 12
Study 20158918 — intervention group
Group type: COMPARATOR
Intervention: No payment for testing
Number of subjects: 12
Study 18672535 — intervention group
Group type: COMPARATOR
Intervention: Ethinyl estradiol (EE) and norethindrone (NE) alone
Number of subjects: 19
Study 18672535 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol (EE) and norethindrone (NE) with darunavir/ritonavir (DRV/r)
Number of subjects: 19
Study 15904555 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational booklet
Number of subjects: 332
Study 15904555 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 332
Study 12322847 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine plus Pseudoephedrine Sulfate Repetabs Tables (LTD+PSE Repetabs) (Loratadine 5 mg + Pseudoephedrine 120 mg) twice daily
Number of subjects: 56
Study 12322847 — intervention group
Group type: COMPARATOR
Intervention: loratadine (5 mg) twice daily and pseudoephedrine (60 mg) quarter daily
Number of subjects: 56
Study 9925128 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mL black currant and apple juice
Number of subjects: 5
Study 9925128 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mL black currant and apple juice
Number of subjects: 5
Study 9925128 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mL black currant and apple juice
Number of subjects: 5
Study 7589375 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline and budesonide turbohalers used twice daily over 12 weeks
Number of subjects: 102
Study 7589375 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological assessment using HADS, IIP, and semi-structured interview
Number of subjects: 102
Study 2156387 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated rotavirus vaccine (derived from rhesus rotavirus strain MMU 18006 and human serotype 1 strain Wa)
Number of subjects: 26
Study 2156387 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated rotavirus vaccine
Number of subjects: 26
Study 7208539 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime short-term prophylaxis (1 day)
Number of subjects: 44
Study 7208539 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin plus oxacillin long-term prophylaxis (5 days)
Number of subjects: 44
Study 30887824 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral activation (BA) with sexual risk reduction (SRR) counseling
Number of subjects: 41
Study 30887824 — intervention group
Group type: COMPARATOR
Intervention: Control condition (two sessions of SRR)
Number of subjects: 41
Study 28395659 — intervention group
Group type: EXPERIMENTAL
Intervention: Abelmoschus manihot (huangkui capsule, 2.5 g, three times per day)
Number of subjects: 1600
Study 28395659 — intervention group
Group type: COMPARATOR
Intervention: Losartan potassium (100 mg/d)
Number of subjects: 1600
Study 26802783 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab (0.5 mg) + deferred laser (N = 111)
Number of subjects: 828
Study 26802783 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab (0.5 mg) + prompt laser (N = 124)
Number of subjects: 828
Study 26802783 — intervention group
Group type: COMPARATOR
Intervention: Laser/very deferred ranibizumab (N = 198)
Number of subjects: 828
Study 26802783 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone (4 mg) + laser/very deferred ranibizumab (N = 125)
Number of subjects: 828
Study 24979561 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 80
Study 24979561 — intervention group
Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 80
Study 22249272 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine and S-1 (GS)
Number of subjects: 117
Study 22249272 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine alone (G)
Number of subjects: 117
Study 20538021 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain patients
Number of subjects: 19
Study 20538021 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 19
Study 18187961 — intervention group
Group type: EXPERIMENTAL
Intervention: E-CMF (adjuvant anthracycline-based dose-dense sequential chemotherapy)
Number of subjects: 595
Study 18187961 — intervention group
Group type: EXPERIMENTAL
Intervention: E-T-CMF (adjuvant anthracycline-based dose-dense sequential chemotherapy)
Number of subjects: 595
Study 15819813 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreas-kidney transplantation (PTx)
Number of subjects: 48
Study 15819813 — intervention group
Group type: COMPARATOR
Intervention: Control group of nontransplanted type 1 diabetic patients
Number of subjects: 48
Study 12390062 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (≤325 mg/d)
Number of subjects: 6300
Study 9090581 — intervention group
Group type: EXPERIMENTAL
Intervention: Triggered images (with respiratory triggering)
Number of subjects: 10
Study 9090581 — intervention group
Group type: EXPERIMENTAL
Intervention: Triggered images with echo train length of 8 and flow compensation
Number of subjects: 10
Study 9090581 — intervention group
Group type: COMPARATOR
Intervention: Nontriggered images
Number of subjects: 10
Study 7947873 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Number of subjects: 0
Study 3606936 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12
Study 3606936 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 12
Study 29438131 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 74
Study 27682300 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct cortical fixation using spiked washer screw (group I)
Number of subjects: 80
Study 27682300 — intervention group
Group type: COMPARATOR
Intervention: Post-tie using washer screw (group II)
Number of subjects: 80
Study 25051491 — intervention group
Group type: EXPERIMENTAL
Intervention: Xpert MTB/Rif test on pleural fluid
Number of subjects: 116
Study 25051491 — intervention group
Group type: COMPARATOR
Intervention: Pleural tissue culture and/or histopathology (reference standard)
Number of subjects: 116
Study 22623392 — intervention group
Group type: COMPARATOR
Intervention: MUFA diet (20% daily energy MUFA)
Number of subjects: 0
Study 22623392 — intervention group
Group type: COMPARATOR
Intervention: MED diet (21% daily energy MUFA)
Number of subjects: 0
Study 22623392 — intervention group
Group type: EXPERIMENTAL
Intervention: SFA diet (19% daily energy as SFA)
Number of subjects: 0
Study 19793143 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroanatomic mapping (EAM) and ablation of MRAT with linear ablation at the mid‐diastolic isthmus (MDI).
Number of subjects: 52
Study 19793143 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroanatomic mapping (EAM) and ablation of MRAT.
Number of subjects: 52
Study 19198574 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily interferon alpha‐2b (4 MIU s.c. for patients > 65 kg or 0.06 MIU/kg < 65 kg) + ribavirin
Number of subjects: 336
Study 19198574 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐interferon alpha‐2b (100 microg s.c. weekly for patients > 65 kg or 1.5 microg/kg weekly for patients < 65 kg) + ribavirin
Number of subjects: 336
Study 19198574 — intervention group
Group type: COMPARATOR
Intervention: Interferon alpha‐2b (3 MIU s.c. TIW) + ribavirin
Number of subjects: 336
Study 16370079 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (Zyprexa) 7.5 mg
Number of subjects: 1493
Study 16370079 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (Seroquel) 200 mg
Number of subjects: 1493
Study 16370079 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (Risperdal) 1.5 mg
Number of subjects: 1493
Study 16370079 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone (Geodon) 40 mg
Number of subjects: 1493
Study 16370079 — intervention group
Group type: EXPERIMENTAL
Intervention: Perphenazine (Trilafon) 8 mg
Number of subjects: 1493
Study 15156097 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine high dose (12 mg)
Number of subjects: 18
Study 15156097 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine low dose (4 mg)
Number of subjects: 18
Study 15156097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 15156097 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine (both doses)
Number of subjects: 18
Study 11122312 — intervention group
Group type: EXPERIMENTAL
Intervention: ILM airway insertion/intubation
Number of subjects: 120
Study 11122312 — intervention group
Group type: EXPERIMENTAL
Intervention: ILM removal at 1 min
Number of subjects: 120
Study 11122312 — intervention group
Group type: COMPARATOR
Intervention: ILM removal at 3 min
Number of subjects: 120
Study 11122312 — intervention group
Group type: COMPARATOR
Intervention: ILM removal at 5 min
Number of subjects: 120
Study 11122312 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple intubation attempts
Number of subjects: 120
Study 11122312 — intervention group
Group type: EXPERIMENTAL
Intervention: ILM insertion/intubation and removal
Number of subjects: 120
Study 11122312 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing of ILM removal
Number of subjects: 120
Study 9251961 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal arithmetic task presented first
Number of subjects: 20
Study 9251961 — intervention group
Group type: COMPARATOR
Intervention: Nonverbal arithmetic task
Number of subjects: 20
Study 9251961 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal arithmetic task presented second
Number of subjects: 20
Study 8337193 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment programme in a group setting with components of relaxation, cognitive restructuring, and promotion of well-being
Number of subjects: 0
Study 8337193 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment programme
Number of subjects: 0
Study 3709586 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine injection (group A)
Number of subjects: 98
Study 3709586 — intervention group
Group type: COMPARATOR
Intervention: No epidural morphine (group B)
Number of subjects: 98
Study 3169499 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (starting dosage, 2.5 mg/kg.day)
Number of subjects: 12
Study 3169499 — intervention group
Group type: COMPARATOR
Intervention: Vehicle placebo
Number of subjects: 12
Study 31552428 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep intervention (n = 50)
Number of subjects: 100
Study 31552428 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 50)
Number of subjects: 100
Study 31284074 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose colchicine (0.5 mg daily)
Number of subjects: 237
Study 31284074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study 27613939 — intervention group
Group type: EXPERIMENTAL
Intervention: 6mg nicotine gum
Number of subjects: 94
Study 27613939 — intervention group
Group type: COMPARATOR
Intervention: 4mg nicotine lozenge
Number of subjects: 94
Study 27613939 — intervention group
Group type: COMPARATOR
Intervention: 4mg lozenge
Number of subjects: 94
Study 27613939 — intervention group
Group type: COMPARATOR
Intervention: 4mg gum
Number of subjects: 94
Study 27613939 — intervention group
Group type: EXPERIMENTAL
Intervention: 2mg nicotine gum
Number of subjects: 94
Study 27613939 — intervention group
Group type: COMPARATOR
Intervention: 4mg nicotine gum
Number of subjects: 94
Study 26003545 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume strategy (4 to 6 ml/kg PBW)
Number of subjects: 0